… increased risk of early HCC recurrence in patients undergoing treatment with DAAs, it is
clear that the risk of early HCC recurrence in patients with HCV-related cirrhosis remains high …

… , mostly within the first six months after antiviral therapy. However, these data should be …
and duration of liver cirrhosis before DAA treatment. This clearly affects the degree of confidence …

… treatments; the CirVir cohort, comprised HCV patients … of cirrhosis; and the CUPILT cohort,
comprised HCV patients … findings of lower rates of early HCC recurrence is probably related to …

… without reducing it to zero and therefore cirrhotic patients with treated HCV should continue
to … treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. J …

… treated cirrhotic patients who achieved SVR. Additionally, despite DAA treatment, a high risk
of tumor recurrence in the … at early stages in one large, single-center cohort of patients with …

… . Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by
treatment with direct-acting antivirals? A prospective multicentre study. Aliment Pharmacol Ther …

… cohort of DAA-treated cirrhotic patients found that a genetic … cirrhosis as an independent
risk factor for HCC recurrence. … rates of cirrhosis in patients developing recurrent HCC might …

… Cirrhosis due to chronic infection with hepatitis C virus (HCV) is a leading risk … treatment.
Our results indicate that DAA could lead to a lower recurrence risk in early stage hepatitis C virus…

… hepatitis, leading to cirrhosis and hepatocellular carcinoma (HCC… therapy can reduce the
risk of HCC recurrence in patients … Reig reported the early tumor recurrence of 20 HCV patients …

… study is the first to assess the prognosis and recurrence rate … HCV-associated hepatocellular
carcinoma tends to develop … diagnosed cirrhosis based on clinical findings in all patients in …